Earlier work of our group could identify TRM as key candidates for long-lasting protective immunity and it could be shown that they are highly functional when expressing PD-1 and TIM-3 in lung cancer and melanoma (11, 12). This evidence concerns the gene HAVCR2 and lung cancer.